Literature DB >> 2161770

In vitro comparison of HMPAO and gentisic acid for labelling leukocytes with 99mTc.

M Ecclestone1, A Proulx, J R Ballinger, B Gerson, R H Reid, K Y Gulenchyn.   

Abstract

Leukocytes can be labelled with 99mTc using HMPAO and gentisic acid methods. We compared the two methods with respect to labelling efficiency on mixed leukocytes and isolated polymorphonuclear (PMN) and mononuclear (MN) cells, and the in vitro stability of the label. HMPAO produced approximately 70% labelling efficiency on mixed or PMN cells and the label was stable in saline or plasma. Labelling efficiency on MN was only 14% and was less stable. Gentisic acid produced a labelling efficiency of 52% on PMN and 35% on MN; both were stable in saline but less stable in plasma. In conclusion, HMPAO produces higher labelling efficiency and the label shows greater in vitro stability in plasma. However, gentisic acid is much less expensive to use, allows labelling of MN cells, and should result in more favourable microdosimetry. Preliminary clinical results suggest that gentisic acid is equivalent to HMPAO but has the advantage of being much cheaper.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2161770     DOI: 10.1007/BF00842783

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  13 in total

1.  Labeling of phagocytes from human blood with 99mTc-sulfur colloid.

Authors:  D English; B R Andersen
Journal:  J Nucl Med       Date:  1975-01       Impact factor: 10.057

2.  Radiochemical purity of [99mTc]HM-PAO.

Authors:  J R Ballinger; R H Reid; K Y Gulenchyn
Journal:  J Nucl Med       Date:  1988-04       Impact factor: 10.057

3.  Tc-99m-HMPAO: a new platelet labelling compound?

Authors:  W Becker; W Börner; U Borst; E P Kromer; K R Gruner
Journal:  Eur J Nucl Med       Date:  1987

4.  Localization and stability of technetium-99m-Sn-pyrophosphate in rat neutrophils.

Authors:  R F Schmelter; C Y Loo
Journal:  J Nucl Med       Date:  1988-08       Impact factor: 10.057

5.  Technetium-99m labeling of polymorphonuclear leukocytes: preparation with two different stannous agents.

Authors:  H Kelbaek; J Fogh
Journal:  J Nucl Med       Date:  1985-01       Impact factor: 10.057

Review 6.  Imaging of inflammatory processes with labeled cells.

Authors:  J W Froelich; D Swanson
Journal:  Semin Nucl Med       Date:  1984-04       Impact factor: 4.446

7.  Tc-99m labeled leukocytes: preparation and use in identification of abscess and tissue rejection.

Authors:  N A Farid; S M White; L L Heck; E D Van Hove
Journal:  Radiology       Date:  1983-09       Impact factor: 11.105

8.  A new technique for formation of 99mTc-labelled blood leucocytes and platelets.

Authors:  E Sundrehagen
Journal:  Int J Appl Radiat Isot       Date:  1984-05

9.  Identification of factors affecting technetium 99m leucocyte labelling by phagocytic engulfment and development of an optimal technique.

Authors:  R W Hanna; F E Lomas
Journal:  Eur J Nucl Med       Date:  1986

10.  In vivo kinetics of canine leukocytes labeled with technetium-99m HM-PAO and indium-111 tropolonate.

Authors:  B H Mock; D S Schauwecker; D English; K A Young; H N Wellman
Journal:  J Nucl Med       Date:  1988-07       Impact factor: 10.057

View more
  3 in total

1.  Labelling of leucocytes with technetium-99m exametazime causes in vitro upregulation of granulocyte CD11b without correlation to tissue uptake in vivo.

Authors:  S Almer; O Ljunghusen; J Lundahl
Journal:  Eur J Nucl Med       Date:  1996-06

2.  99mTc labeling white blood cells with a simple technique: clinical application.

Authors:  B Gutfilen; M P Pellini; J de Roure e Neder; J L de Amarante Júnior; M G Evangelista; S R Fernandes; M Bernardo-Filho
Journal:  Ann Nucl Med       Date:  1994-02       Impact factor: 2.668

3.  Technetium-99m HMPAO labeled leukocytes in inflammation imaging.

Authors:  K Uno; K Yoshikawa; K Imazeki; S Minoshima; N Arimizu
Journal:  Ann Nucl Med       Date:  1991-07       Impact factor: 2.668

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.